Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04042116
Title A Study to Evaluate Lucitanib in Combination With Nivolumab in Patients With a Solid Tumor
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Clovis Oncology, Inc.

Advanced Solid Tumor

female reproductive organ cancer


Lucitanib + Nivolumab

Age Groups: adult | senior
Covered Countries USA | ITA | ESP | DEU | BEL | AUT

No variant requirements are available.